Pharmacokinetics of voriconazole in the cerebrospinal fluid of an immunocompromised patient with a brain abscess due to Aspergillus fumigatus [5]

Clinical Infectious Diseases

Volumn 39, Issue 4, 2004, Pages 603-604

  Denes, E ^a   Pichon, N ^a   Debette Gratien, M ^a   Bouteille, B ^a   Gaulier, J M ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

METOPIMAZINE; NICARDIPINE; PAROXETINE; PRAZOSIN; TACROLIMUS; VORICONAZOLE;

ADULT; ANTIBIOTIC THERAPY; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRAIN ABSCESS; CASE REPORT; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; FEMALE; HUMAN; IMMUNE DEFICIENCY; LETTER; PRIORITY JOURNAL;

ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BRAIN ABSCESS; CEREBROSPINAL FLUID; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; MIDDLE AGED; PYRIMIDINES; TRIAZOLES;

EID: 4344564936     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/422526     Document Type: Letter

References (4)

1. Lutsar I, Roffey S, Troke P. Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients. Clin Infect Dis 2003; 37:728-32.
2. Espinel-Ingroff A, Chaturvedi V, Fothergill A, Rinaldi MG. Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study. J Clin Microbiol 2002; 40:3776-81.
3. Schwartz S, Milatovic D, Thiel E. Successful treatment of cerebral aspergillosis with a novel triazole (voriconazole) in a patient with acute leukaemia. Br J Haematol 1997; 97:663-5.
4. Venkataramanan R, Zang S, Gayowski T, Singh N. Voriconazole inhibition of the metabolism of tacrolimus in a liver transplant recipient and in human liver microsomes. Antimicrob Agents Chemother 2002; 46:3091-3.